Diadia
Our TechnologyResearchResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResourcesResearch
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResourcesResearch
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

endocrine · Mechanism Report

Does low DHEA sulfate indicate reduced adrenal androgen output without proving adrenal insufficiency?

Low DHEA sulfate can reflect reduced adrenal androgen output, but it does not by itself diagnose adrenal insufficiency.

PlausibleOctober 26, 20269 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

DHEA sulfate is produced mainly by the adrenal cortex and declines markedly with age, so low DHEA sulfate can indicate reduced adrenal androgen output, though not adrenal insufficiency.

laying out figure…
4 of 7 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim says DHEA sulfate is mainly made by the adrenal cortex and tends to fall with age, so a low value may be expected in some older adults. The mechanism framing also notes that DHEA-S reflects adrenal androgen production and can be lowered by glucocorticoid exposure, which is why it is not specific for adrenal insufficiency on its own.

Verified conclusion

DHEA sulfate (DHEA-S) is a predominantly adrenal androgen marker whose interpretation is strongly age-, sex-, assay-, and medication-dependent. For a 70-year-old man, a low result may be physiologically expected to some degree and should not be equated with adrenal failure.

Physiology and age-related change

  • DHEA-S is produced mainly in the adrenal cortex’s zona reticularis. CYP17A1 supports DHEA synthesis, and SULT2A1 converts DHEA to DHEA-S.
  • Production is ACTH-responsive, linking circulating DHEA-S to adrenal androgen output.
  • Male longitudinal cohorts estimate average DHEA-S declines of approximately 2–4% per year with aging: 4.0% annually in Rancho Bernardo over 10–14 years and about 2–3% annually in Massachusetts Male Aging Study data.
  • Individual trajectories vary substantially. In PAQUID, the estimated annual decrease was 2.3%, but 40% of participants had higher follow-up values. In one male population sample, the median at ages 70–74 was 89 μg/dL, although laboratory intervals differ materially by assay.

Clinical interpretation

  • A low DHEA-S relative to an age- and sex-specific laboratory range can indicate reduced adrenal androgen output, particularly when interpreted alongside symptoms, ACTH status, cortisol results, and medication exposure.
  • Glucocorticoid treatment can suppress ACTH and adrenal androgen production; low DHEA-S may persist after exposure.

Adrenal-insufficiency implications

  • Low DHEA-S is not diagnostic of adrenal insufficiency. In one cohort, DHEA-S below 100 μg/dL had 90% sensitivity but only 43% specificity for cosyntropin-defined adrenal insufficiency.
  • Evaluation of suspected adrenal insufficiency should use morning cortisol with ACTH and, when indicated, 250-µg cosyntropin stimulation testing.

Bottom line

  • The claim is well supported: DHEA-S is mainly adrenal in origin and declines markedly on average with age; a low value can support reduced adrenal androgen output but cannot, by itself, establish adrenal insufficiency.

References

  1. longitudinal study of dehydroepiandrosterone sulphate (DHEAS ... — academic.oup.com ↗
  2. Prospective measurements of dehydroepiandrosterone sulfate in a cohort of elderly subjects: Relationship to gender, subjective health, smoking habits, and 10-year mortality | PNAS — pnas.org ↗
  3. Endocrinology of the Aging Male - PMC - NIH — pmc.ncbi.nlm.nih.gov ↗
  4. Adrenal Androgens and Aging - Endotext - NCBI Bookshelf — ncbi.nlm.nih.gov ↗
  5. Society for Endocrinology Clinical Practice Guideline for the ... — onlinelibrary.wiley.com ↗
  6. transformed serum dehydroepiandrosterone sulfate in patients with ... — jstage.jst.go.jp ↗
  7. Adrenal Insufficiency - Endotext - NCBI Bookshelf - NIH — ncbi.nlm.nih.gov ↗
  8. Serum dehydroepiandrosterone sulfate in assessing the integrity of ... — pmc.ncbi.nlm.nih.gov ↗
  9. Performance of Dehydroepiandrosterone Sulfate and Baseline ... — academic.oup.com ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesDoes aging reduce Leydig-cell number and testosterone reserve?→Plausible6 sourcesCan reduced hypothalamic-pituitary stimulation cause low testosterone, and do LH and FSH help distinguish central from primary hypogonadism?→